Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−6.69 USD
−5.34 M USD
0.00 USD
30.11 M
About Oruka Therapeutics, Inc.
Sector
CEO
Lawrence O. Klein
Website
Headquarters
Menlo Park
FIGI
BBG000BWNN28
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ORKA is 19.93 USD — it has decreased by −0.45% in the past 24 hours. Watch Oruka Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Oruka Therapeutics, Inc. stocks are traded under the ticker ORKA.
ORKA stock has fallen by −14.94% compared to the previous week, the month change is a −25.00% fall, over the last year Oruka Therapeutics, Inc. has showed a −92.67% decrease.
We've gathered analysts' opinions on Oruka Therapeutics, Inc. future price: according to them, ORKA price has a max estimate of 49.00 USD and a min estimate of 40.00 USD. Watch ORKA chart and read a more detailed Oruka Therapeutics, Inc. stock forecast: see what analysts think of Oruka Therapeutics, Inc. and suggest that you do with its stocks.
ORKA reached its all-time high on Feb 18, 2000 with the price of 687,346,580,217.64 USD, and its all-time low was 21.72 USD and was reached on Aug 29, 2024. View more price dynamics on ORKA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ORKA stock is 19.94% volatile and has beta coefficient of 0.20. Track Oruka Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Oruka Therapeutics, Inc. there?
Today Oruka Therapeutics, Inc. has the market capitalization of 776.97 M, it has decreased by −7.50% over the last week.
Yes, you can track Oruka Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Oruka Therapeutics, Inc. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
ORKA earnings for the last quarter are −1.46 USD per share, whereas the estimation was −0.40 USD resulting in a −263.27% surprise. The estimated earnings for the next quarter are −0.67 USD per share. See more details about Oruka Therapeutics, Inc. earnings.
Oruka Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ORKA net income for the last quarter is −28.62 M USD, while the quarter before that showed −2.68 M USD of net income which accounts for −968.82% change. Track more Oruka Therapeutics, Inc. financial stats to get the full picture.
As of Nov 21, 2024, the company has 5.00 employees. See our rating of the largest employees — is Oruka Therapeutics, Inc. on this list?
Like other stocks, ORKA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Oruka Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Oruka Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Oruka Therapeutics, Inc. stock shows the sell signal. See more of Oruka Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.